Global Radiopharmaceuticals Market: Detailed Analysis, Shares, Size and Forecast Up To 2021

By , in Uncategorized on .

The Radiopharmaceuticals Market report provides useful information of the Radiopharmaceuticals market along with the price forecast for the forecast period of 2017-2021. The report presents the detailed analysis of the parent market based on elite players, present, past & futuristic data which will serve as a profitable guide for all the Radiopharmaceuticals market competitors. Key Radiopharmaceuticals market data like market drivers, challenges, trends & technological developments are also discussed in this report.

With thorough market segment in terms of different Countries, this report divides the Radiopharmaceuticals market into key countries coupled with figures of sales (consumption), revenue, market share, and growth rate in these countries over the forecast period 2017-2021.

Leading vendors in the Radiopharmaceuticals Market Space: Bayer, Cardinal Health, GE Healthcare, Lantheus Medical Imaging, ABT Molecular Imaging, Advanced Accelerator Applications, Algeta, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, Isologic Innovative Radiopharmaceuticals, Nordion, Piramal Imaging, RadioMedix, and Triad Isotopes

History Year: 2013-2017 | Base Year: 2017 | Forecast Year: 2017 – 2021 | No. Of Pages: 101

Get a sample pdf of Radiopharmaceuticals market report @

About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical Market is expected to benefit from the growing demand from the cancer Market . Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.

Industry analysts forecast the global radiopharmaceuticals Market to grow at a CAGR of 9.02% during the period 2017-2021.

Market driver

  • Rising burden of the neurological disorders
  • For a full, detailed list, view our report

Market challenge

  • Shortage of radioisotopes
  • For a full, detailed list, view our report

Market trend

  • Partnerships for development of radiopharmaceuticals
  • For a full, detailed list, view our report

If you have any special requirements enquire @

Questions related to the Radiopharmaceuticals Market present industry size, share, revenue & future forecast for the period 2017-2021 answered in the report:

  • What are the strengths & weaknesses of the key vendors?
  • What are the challenges & opportunities for a new entrant?
  • Who are the leading manufacturers in the Radiopharmaceuticals Market?
  • What is the share, revenue, size, year-over-year growth rate of key vendors in APEC, EMEA & Americas region?
  • What will be the market growth rate of the Radiopharmaceuticals Market in the year 2021?
  • What are major drivers of the Radiopharmaceuticals Market?

Scope of the report:

This report focuses on the Radiopharmaceuticals Market global as well as regional market in regions of APEC, EMEA, Americas. Report is categorized based on the manufacturers, regions & application. Key manufacturers are elaborately discussed in this report along with their revenue in promising regions (North America, Europe, Asia-Pacific, South America, Middle East & Africa).

Purchase full detailed Radiopharmaceuticals market report for $3500 @